Earnings Feed
Start Free
Home/Filings/3/0001062993-21-005352
3//SEC Filing

VEDANTA PARTNERS, LLC 3

Accession 0001062993-21-005352

CIK 0001742927other
View on SEC.govCompany Profile

Filed

Jun 2, 8:00 PM ET

Accepted

Jun 3, 5:29 PM ET

Size

9.5 KB

Accession

0001062993-21-005352

Insider Transaction Report

Form 3
Period: 2021-06-01
REVIVA PHARMACEUTICALS HOLDINGS, INC.RVPH
Vedanta Associates-R, LP
10% Owner
Holdings

  • Common Stock

    (indirect: See Footnote)
    99,539
VEDANTA ASSOCIATES, L.P.
10% Owner
Holdings

  • Common Stock

    (indirect: See Footnote)
    99,539
BETA OPERATORS FUND, L.P.
10% Owner
Holdings

  • Common Stock

    (indirect: See Footnote)
    99,539
VEDANTA PARTNERS, LLC
10% Owner
Holdings

  • Common Stock

    (indirect: See Footnote)
    99,539
Footnotes (1)
  • [F1]Held directly by Vedanta Associates, L.P. ("Vedanta Associates"). Vedanta Partners, LLC ("Vedanta Partners") is the general partner of Vedanta Associates, and Parag Saxena is the majority member of Vedanta Partners. Each of Vedanta Partners and Mr. Saxena disclaim beneficial ownership of the securities reported herein, except to the extent of any pecuniary interest therein.

Documents

1 file

Issuer

REVIVA PHARMACEUTICALS HOLDINGS, INC.

CIK 0001742927

→
Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001502216

Filing Metadata

Form type
3
Filed
Jun 2, 8:00 PM ET
Accepted
Jun 3, 5:29 PM ET
Size
9.5 KB
View on SEC.gov